Wang Kai, Ho Shiuh-Rong, Mao Weiming, Huang Ping, Zhang Fengxue, Schwiebert Erik M, Kudlow Jeffrey E, Paterson Andrew J
Department of Medicine, Division of Endocrinology, Diabetes and metabolism, University of Alabama at Birmingham, 1808 7th Avenue South, Birmingham, AL 35294, USA.
Biochem Biophys Res Commun. 2009 Sep 11;387(1):70-6. doi: 10.1016/j.bbrc.2009.06.132. Epub 2009 Jul 3.
Diminished proteolytic functionality in the lens may cause cataracts. We have reported that O-GlcNAc is an endogenous inhibitor of the proteasome. We hypothesize that in the lens there is a cause-and-effect relationship between proteasome inhibition by O-GlcNAc, and cataract formation. To demonstrate this, we established novel transgenic mouse models to over-express a dominant-negative form of O-GlcNAcase, GK-NCOAT, in the lens. Expression of GK-NCOAT suppresses removal of O-GlcNAc from proteins, resulting in increased levels of O-GlcNAc in the lenses of our transgenic mice, along with decreased proteasome function. We observed that transgenic mice developed markedly larger cataracts than controls and lens fiber cell denucleation was inhibited. Our study suggests that increased O-GlcNAc in the lens could lead to cataract formation and attenuation of lens fiber cell denucleation by inhibition of proteasome function. These findings may explain why cataract formation is a common complication of diabetes since O-GlcNAc is derived from glucose.
晶状体中蛋白水解功能的减弱可能会导致白内障。我们曾报道过O-连接的N-乙酰葡糖胺(O-GlcNAc)是蛋白酶体的一种内源性抑制剂。我们推测,在晶状体中,O-GlcNAc对蛋白酶体的抑制作用与白内障形成之间存在因果关系。为了证明这一点,我们建立了新型转基因小鼠模型,使其在晶状体中过表达一种显性负性形式的O-GlcNAcase,即GK-NCOAT。GK-NCOAT的表达抑制了蛋白质上O-GlcNAc的去除,导致我们转基因小鼠晶状体中O-GlcNAc水平升高,同时蛋白酶体功能下降。我们观察到,转基因小鼠形成的白内障明显比对照小鼠大,并且晶状体纤维细胞的去核过程受到抑制。我们的研究表明,晶状体中O-GlcNAc的增加可能通过抑制蛋白酶体功能导致白内障形成以及晶状体纤维细胞去核过程的减弱。这些发现可能解释了为什么白内障形成是糖尿病的常见并发症,因为O-GlcNAc来源于葡萄糖。